Breastcancer-genetics
2011 – 2020 of 2274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families
(
- Contribution to journal › Article
-
Mark
Low frequency of E-cadherin alterations in familial breast cancer
(
- Contribution to journal › Article
-
Mark
Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium
(
- Contribution to journal › Article
-
Mark
N-unsubstituted glucosamine in heparan sulfate of recycling glypican-1 from suramin-treated and nitrite-deprived endothelial cells. mapping of nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein
(
- Contribution to journal › Article
-
Mark
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk
(
- Contribution to journal › Article
-
Mark
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
(
- Contribution to journal › Article
-
Mark
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
(
- Contribution to journal › Article
-
Mark
Abnormal nuclear shape in solid tumors reflects mitotic instability
(
- Contribution to journal › Article
-
Mark
Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites
(
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
(
- Contribution to journal › Article